What exactly is the board meeting about?

The board will discuss a strategic joint venture and an NCD allotment. No other specifics have been given.

Why is the filing so vague?

It is a procedural intimation under Regulation 29. Detailed proposals typically follow only after board approval.

Could this JV be significant for the company?

It could be, given the nano-cap size (₹17 cr market cap). But without a counterparty or investment amount, it is impossible to judge.

What is Gilada Finance's current financial state?

Trailing revenue growth is **4.8%**, while PAT has declined **14.5%**. Debt/equity is low at **0.42**, and ROE is **8.9%**.

What does the NCD allotment indicate?

It suggests the company may be raising debt capital, possibly to fund the JV or for working capital. Terms remain unknown.

Stock Broking · Micro cap

Gilada Finance board to weigh JV, NCD allotment

Nano-cap firm with ₹17 cr market cap mulls strategic move; no counterparty or investment details disclosed yet.

— 1 earlier story on Gilada Finance & Investments Ltd. →

GILADAFINS By Tipsheet Editorial 15 Jun 2026 · 3:29 PM IST Verify on BSE · NSE

Mkt cap₹20.22 cr

P/E9.30×

ROE8.87%

Debt / eq.0.42

₹17 cr Market capitalisation

What's new

Board meeting called to consider a strategic joint venture.
NCD allotment also on the agenda, amount unspecified.
Filing provides no counterparty, investment size, or terms.

Why this matters

For a company with trailing PAT down 14.5% and ROE of 8.9%, a JV could be a pivot. But the total absence of detail makes this a placeholder. The market knows nothing about execution or scale.

What we're watching

Counterparty disclosure and credibility.
Investment size relative to the ₹17 cr market cap.
NCD terms. Debt or convertible?

The full read

Gilada Finance's board will meet to weigh a strategic joint venture and an NCD allotment. That is all the filing says. For a company with a market cap of ₹17 cr, trailing revenue growth of just 4.8%, and a 14.5% drop in PAT, a JV could be a necessary catalyst. But the filing offers zero details. No counterparty, no investment size, no terms. The NCD allotment, similarly unspecified, hints at a capital raise but nothing more. This is a preliminary disclosure, not an actionable event. What matters now is what comes after the board meeting: the counterparty's standing, the quantum of investment relative to the company's size, and the debt terms. Until then, the story is a placeholder.

Questions answered

What exactly is the board meeting about?: The board will discuss a strategic joint venture and an NCD allotment. No other specifics have been given.
Why is the filing so vague?: It is a procedural intimation under Regulation 29. Detailed proposals typically follow only after board approval.
Could this JV be significant for the company?: It could be, given the nano-cap size (₹17 cr market cap). But without a counterparty or investment amount, it is impossible to judge.
What is Gilada Finance's current financial state?: Trailing revenue growth is 4.8%, while PAT has declined 14.5%. Debt/equity is low at 0.42, and ROE is 8.9%.
What does the NCD allotment indicate?: It suggests the company may be raising debt capital, possibly to fund the JV or for working capital. Terms remain unknown.

Mentioned: Gilada Finance & Investments Ltd · ₹17 cr market cap

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Gilada Finance & Investments Ltd.

Asset Management

₹20 cr

P/E 9.30×

Latest quarter · Mar 2026

Total income₹2 cr

Net profit₹0 cr

Net margin+24.5%

EPS₹0.33

Leverage & growth

Debt / equity0.42×

Sales CAGR+12.3%

EPS CAGR+10.2%

Story so far

All notes on GILADAFINS →

15 Jun 2026 · 3:29 PM IST Gilada Finance board to weigh JV, NCD allotment
17d ago Gilada Finance forms JV with Harley of London India